Advertisement

Insulin and glucagon infusion therapy in acute alcoholic hepatitis

  • J. Fehér
  • A. Cornides
  • A. Gógl
  • A. Romány
  • M. Kárteszi
  • L. Szalay
  • J. Picazo
Chapter
  • 20 Downloads

Abstract

Alcohol consumption is probably the commonest self-induced injury to the liver nowadays, and the most frequent cause of chronic liver disease. In Western countries the incidence of liver cirrhosis can be directly related to the quantity of consumed alcohol. The death rate in different communities correlates quite well with alcohol consumption1. Table 8.1 shows alcohol consumption (absolute alcohol in litres) in 1983, according to data from the World Health Organization. However, these data vary and, for instance, in the last ten years the consumption of alcohol per capita has decreased in France and increased in Hungary.

Keywords

Prothrombin Time Hepatic Encephalopathy Alcoholic Liver Disease Alcoholic Hepatitis Hepatic Coma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Sherlock S. Alcohol related liver disease. Br Med Bull 1982; 38: 67–70.PubMedGoogle Scholar
  2. 2.
    Fehér J. Pathogenesis and prognosis of chronic active hepatitis. PhD Thesis, Semmelweis University of Budapest, 1980.Google Scholar
  3. 3.
    Sherlock S. Nutrition and alcoholics. Lancet 1984; 1: 436–438.PubMedCrossRefGoogle Scholar
  4. 4.
    Phillips BG, Davidson GS. Acute hepatic insufficiency of chronic alcoholic. Arch Int Med 1954; 94: 585–603.Google Scholar
  5. 5.
    Galambos JT. Natural history of alcoholic hepatitis. Part 3. Histological changes. Gastroenterology 1972; 63: 1026–1035.PubMedGoogle Scholar
  6. 6.
    Pares A, Caballeria J, Bruguera M, Rodés J. Histological course of alcoholic hepatitis. Influence of abstinence, sex, and extent of hepatic damage. J Hepatol 1986; 2: 33–42.PubMedCrossRefGoogle Scholar
  7. 7.
    Porter HP, Simon RF, Pope CE, Vollwiller W, Fenster LF. Corticosteroid therapy in severe alcoholic hepatitis: A double blind drug trial. N Engl J Med 1971; 284: 1350–1355.PubMedCrossRefGoogle Scholar
  8. 8.
    Maddrey WC, Boinott JK, Bedine MS, Weber FL, Mezey E, White RI. Corticosteroid therapy of alcoholic hepatitis. Gastroenterology 1978; 75: 193–199.PubMedGoogle Scholar
  9. 9.
    Dölle W. Drug therapy in liver disease. Hematology Rapid Literature Review, Freiburg 1985; 6: 11–12.Google Scholar
  10. 10.
    Tescke R, Matrini GA, Strohmeyer G. Was ist gesichert in der Therapie toxisch bedingter Lebererkrankungen? Internist 1983; 24: 690–698.Google Scholar
  11. 11.
    Fehér J, Láng I, Nékám K, Csomós G, Müzes G, Deák G. Effect of silibinin on the activity and expression of superoxide dismutase (SOD) in lymphocytes from patients with chronic alcoholic liver disease. Free Radical Res Commun 1987; in press.Google Scholar
  12. 12.
    Farivar M, Wands JR, Isselbacher KJ, Bucher NLR. Effect of insulin and glucagon on fulminant murine hepatitis. N Engl J Med 1976; 295: 1517–1519.PubMedCrossRefGoogle Scholar
  13. 13.
    Baker AL, Jaspan JB, Haines NW, Hatfield GE, Krager PS, Schneider JF. A randomized clinical triad of insulin and glucagon infusion for treatment of alcoholic hepatitis: A progress report in 50 patients. Gastroenterology 1981; 80: 1410–1414.PubMedGoogle Scholar
  14. 14.
    Radvan G, Kanel G, Redeker A. Insulin and glucagon infusion in acute alcoholic hepatitis. Gastroenterology 1982; 82: 1154.Google Scholar
  15. 15.
    Oka H, Okita K, Fujiwara K. Glucagon and insulin therapy in fulminant hepatic failure in Japan. In: Picazo J, ed. Glucagon in Gastroenterology and Hepatology. Lancaster: MTP Press, 1982: 171–178.Google Scholar
  16. 16.
    Sherlock S. Portal venous ‘goodies’ and fulminant viral hepatitis. N Engl J Med 1976; 295: 1535–1536.PubMedCrossRefGoogle Scholar
  17. 17.
    Starzl TE, Porter KA, Watanabe K, Putnam CW. Effect of insulin, glucagon, and insulin/glucagon infusions on liver morphology and cell division after complete portacaval shunt in dogs. Lancet 1976; 1: 821–825.PubMedCrossRefGoogle Scholar
  18. 18.
    Farinati F, Pengo V, Bassi N, Naccarato R, D’Amico D. Monitoring liver regeneration after right hepatectomy. Ital J Surg Sci 1985; 15: 75–77.PubMedGoogle Scholar
  19. 19.
    Fehér J, Vereckei A. Free Radical Reactions in Medicine. Budapest: Biogal-Medicina, 1985.Google Scholar

Copyright information

© MTP Press Limited 1987

Authors and Affiliations

  • J. Fehér
  • A. Cornides
  • A. Gógl
  • A. Romány
  • M. Kárteszi
  • L. Szalay
  • J. Picazo

There are no affiliations available

Personalised recommendations